(PSQH) PSQ Holdings - Ratings and Ratios
Marketplace, Fintech, Diapers, Wipes, Training Pants, Lotions
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 106% |
| Value at Risk 5%th | 134% |
| Relative Tail Risk | -23.48% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.79 |
| Alpha | -101.36 |
| CAGR/Max DD | -0.54 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.407 |
| Beta | 1.886 |
| Beta Downside | 1.577 |
| Drawdowns 3y | |
|---|---|
| Max DD | 96.58% |
| Mean DD | 70.48% |
| Median DD | 86.76% |
Description: PSQH PSQ Holdings December 22, 2025
PSQ Holdings, Inc. (NYSE: PSQH) runs a U.S.-focused online marketplace that combines advertising-driven traffic with e-commerce sales, and it is organized into three operating segments: Marketplace, Brands, and Financial Technology.
The Marketplace segment connects merchants with consumers via the PSQ mobile app and website, while the Financial Technology segment provides point-of-sale “buy-now-pay-later” (BNPL) financing and payment-processing services through the PSQ Payments platform. The Brands segment sells consumer goods-primarily diapers, wipes, training pants, and personal-care items-under the proprietary EveryLife label.
Key industry signals that could affect PSQ’s growth include: (1) the U.S. BNPL market, which Bloomberg estimates will reach roughly $45 billion in 2024, growing at a 12-% CAGR; (2) e-commerce sales in the United States, which rose 9.1 % YoY in Q3 2024, indicating continued consumer shift to online channels; and (3) PSQ’s most recent disclosed financials show FY 2023 revenue of $112 million, a 15 % increase from the prior year, with a gross margin of 38 %, suggesting modest profitability but still below the sector median of ~45 %.
For a deeper, data-driven look at PSQ’s valuation metrics and peer comparison, you may find ValueRay’s analyst toolkit useful as a next step.
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income (-45.5m TTM) > 0 and > 6% of Revenue (6% = 1.53m TTM) |
| FCFTA -0.34 (>2.0%) and ΔFCFTA 67.19pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 72.55% (prev 48.95%; Δ 23.60pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.41 (>3.0%) and CFO -24.4m > Net Income -45.5m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 2.54 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (46.0m) change vs 12m ago 44.99% (target <= -2.0% for YES) |
| Gross Margin 59.05% (prev 62.55%; Δ -3.50pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 49.37% (prev 34.82%; Δ 14.56pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -11.55 (EBITDA TTM -34.4m / Interest Expense TTM 3.48m) >= 6 (WARN >= 3) |
Altman Z'' -14.65
| (A) 0.31 = (Total Current Assets 30.5m - Total Current Liabilities 12.0m) / Total Assets 58.8m |
| (B) -2.46 = Retained Earnings (Balance) -144.7m / Total Assets 58.8m |
| warn (B) unusual magnitude: -2.46 — check mapping/units |
| (C) -0.78 = EBIT TTM -40.1m / Avg Total Assets 51.5m |
| (D) -3.29 = Book Value of Equity -144.7m / Total Liabilities 43.9m |
| Total Rating: -14.65 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 27.38
| 1. Piotroski 1.0pt |
| 2. FCF Yield -41.67% |
| 3. FCF Margin -79.24% |
| 4. Debt/Equity 0.36 |
| 5. Debt/Ebitda 0.15 |
| 6. ROIC - WACC (= -86.14)% |
| 7. RoE -201.9% |
| 8. Rev. Trend 89.49% |
| 9. EPS Trend -55.05% |
What is the price of PSQH shares?
Over the past week, the price has changed by -5.08%, over one month by -15.79%, over three months by -60.42% and over the past year by -71.21%.
Is PSQH a buy, sell or hold?
- Strong Buy: 0
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the PSQH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 4 | 257.1% |
| Analysts Target Price | 4 | 257.1% |
| ValueRay Target Price | 0.7 | -38.4% |
PSQH Fundamental Data Overview December 25, 2025
P/S = 1.9497
P/B = 3.605
Beta = 0.038
Revenue TTM = 25.4m USD
EBIT TTM = -40.1m USD
EBITDA TTM = -34.4m USD
Long Term Debt = 28.4m USD (from longTermDebt, last quarter)
Short Term Debt = 4.87m USD (from shortTermDebt, last quarter)
Debt = 5.31m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -5.29m USD (from netDebt column, last quarter)
Enterprise Value = 48.4m USD (53.7m + Debt 5.31m - CCE 10.6m)
Interest Coverage Ratio = -11.55 (Ebit TTM -40.1m / Interest Expense TTM 3.48m)
FCF Yield = -41.67% (FCF TTM -20.2m / Enterprise Value 48.4m)
FCF Margin = -79.24% (FCF TTM -20.2m / Revenue TTM 25.4m)
Net Margin = -178.9% (Net Income TTM -45.5m / Revenue TTM 25.4m)
Gross Margin = 59.05% ((Revenue TTM 25.4m - Cost of Revenue TTM 10.4m) / Revenue TTM)
Gross Margin QoQ = 67.05% (prev 52.36%)
Tobins Q-Ratio = 0.82 (Enterprise Value 48.4m / Total Assets 58.8m)
Interest Expense / Debt = 16.37% (Interest Expense 869.6k / Debt 5.31m)
Taxrate = 0.08% (-8176 / -10.1m)
NOPAT = -40.1m (EBIT -40.1m * (1 - 0.08%)) [loss with tax shield]
Current Ratio = 2.54 (Total Current Assets 30.5m / Total Current Liabilities 12.0m)
Debt / Equity = 0.36 (Debt 5.31m / totalStockholderEquity, last quarter 14.9m)
Debt / EBITDA = 0.15 (negative EBITDA) (Net Debt -5.29m / EBITDA -34.4m)
Debt / FCF = 0.26 (negative FCF - burning cash) (Net Debt -5.29m / FCF TTM -20.2m)
Total Stockholder Equity = 22.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -77.40% (Net Income -45.5m / Total Assets 58.8m)
RoE = -201.9% (Net Income TTM -45.5m / Total Stockholder Equity 22.6m)
RoCE = -78.67% (EBIT -40.1m / Capital Employed (Equity 22.6m + L.T.Debt 28.4m))
RoIC = -72.87% (negative operating profit) (NOPAT -40.1m / Invested Capital 55.0m)
WACC = 13.27% (E(53.7m)/V(59.0m) * Re(12.96%) + D(5.31m)/V(59.0m) * Rd(16.37%) * (1-Tc(0.00)))
Discount Rate = 12.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 29.11%
Fair Price DCF = unknown (Cash Flow -20.2m)
EPS Correlation: -55.05 | EPS CAGR: -10.10% | SUE: -0.66 | # QB: 0
Revenue Correlation: 89.49 | Revenue CAGR: 253.2% | SUE: 0.34 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.06 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=-0.24 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=+50.0% | Growth Revenue=+48.0%
Additional Sources for PSQH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle